Liver Micro Flow - MRI
Public ClinicalTrials.gov record NCT07634939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Magnetic Resonance Imaging (MRI)-Based Quantification of Perfusion and Microstructure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.
Study identification
- NCT ID
- NCT07634939
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
- Last update posted
- Jul 22, 2026
2026 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Liver Diseases trials
Other public records listing Liver Diseases. Sorted by last update posted; newest first. Not a recommendation.
- NCT06068491: Veteran-Centered Care for Advanced Liver Disease (Vet-CALD) Recruiting
- NCT07559474: A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment Recruiting
- NCT00345930: DILIN - Prospective Study Recruiting
- NCT06649864: Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications Not yet recruiting
- NCT05196867: Liver Cancer Prevention Randomized Control Trial Active, not recruiting
- NCT06269510: Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07634939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2026 · Synced Jul 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07634939 live on ClinicalTrials.gov.